« Previous
Next »
The Journal of Pediatrics
Volume 156, Issue 3
, Pages
352-358.e1
, March 2010
Cough in the Pediatric Population
To access this article, please choose from the options below
A.G. is supported by grants from Aerovance, Altana/Nycomed, Capnia, Clinsys, GSK, Johnson & Johnson, Lev Pharmaceuticals, MAP, Schering Plough, and UCB. A.B. serves as a speaker/consultant for Astra Zeneca, Meda, and Merck and received stock options from Apeiron. B.C. is supported by grants from Alcon, Sanofi-Aventis, Genentech, Astra Zeneca, GlaxoSmithKline, Novartis, Schering Plough, Sepracor, and Merck; serves as a consultant for Alcon, Sanofi-Aventis, Genentech, Astra Zeneca, GlaxoSmithKline, MedPointe, Novartis, Schering Plough, Sepracor, and Merck; and serves on the speaker's bureau for Alcon, Sanofi-Aventis, Genentech, Astra-Zeneca, GlaxoSmithKline, MedPointe, Novartis, Schering Plough, Sepracor, Merck, Boehringer Ingelheim, and Pfizer.
PII: S0022-3476(09)01227-X
doi: 10.1016/j.jpeds.2009.12.004
© 2010 Mosby, Inc. All rights reserved.
« Previous
Next »
The Journal of Pediatrics
Volume 156, Issue 3
, Pages
352-358.e1
, March 2010
